Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China.

Journal: Stroke and vascular neurology
PMID:

Abstract

BACKGROUND: Given the swift advancements in artificial intelligence (AI), the utilisation of AI-based clinical decision support systems (AI-CDSSs) has become increasingly prevalent in the medical domain, particularly in the management of cerebrovascular disease.

Authors

  • Zixiao Li
    Beijing Tiantan Hospital, Capital Medical University, Beijing, China. lizixiao2008@hotmail.com.
  • Xinmiao Zhang
    Department of Neurology, Beijing Tiantan Hospital, Beijing, China.
  • Lingling Ding
    Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Jing Jing
  • Hong-Qiu Gu
    China National Clinical Research Center for Neurological Diseases, Beijing, China.
  • Yong Jiang
    Department of Pathology West China Hospital Sichuan University Chengdu China.
  • Xia Meng
    School of Public Health, Fudan University, Shanghai 200032, People's Republic of China.
  • Chunying Du
    China National Clinical Research Center for Neurological Diseases, Beijing, China.
  • Chunjuan Wang
    Department of Neurology, Beijing Tiantan Hospital, Beijing, China.
  • Meng Wang
    State Key Laboratory of Urban Water Resource and Environment, School of Environment, Harbin Institute of Technology, Harbin 150001, China.
  • Man Xu
    Business School, Nankai University, Tianjin 300071, China.
  • Yanxu Zhang
    Hanalytics Artificial Intelligence Research Centre for Neurological Disorders, China National Clinical Research Center for Neurological Diseases, Beijing, China.
  • Meera Hu
    Hanalytics Artificial Intelligence Research Centre for Neurological Disorders, China National Clinical Research Center for Neurological Diseases, Beijing, China.
  • Hao Li
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xiping Gong
    Department of Neurology, Beijing Tiantan Hospital, Beijing, China.
  • Kehui Dong
    Department of Neurology, Beijing Tiantan Hospital, Beijing, China.
  • Xingquan Zhao
    Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China (N.L., J.J., X.Z.); China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China (N.L., W.Y., J.J., Y.J., X.Z.).
  • Yilong Wang
    Department of Neurology, Tiantan Clinical Trial and Research Center for Stroke, Beijing, China.
  • Liping Liu
    Department of Computer Sciences, Tufts University, Medford, MA.
  • Ying Xian
    Duke Clinical Research Institute, Durham, NC.
  • Eric Peterson
    Division of Cardiology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Gregg C Fonarow
    Ahmanson-UCLA Cardiomyopathy Center, Division of Cardiology, Ronald Reagan-UCLA Medical Center, Los Angeles, California.
  • Lee H Schwamm
    Yale School of Medicine, New Haven, Connecticut, USA.
  • Yongjun Wang
    Department of Neurology, Beijing Tiantan Hospital, Beijing, China.